Phase IIb randomized CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked or autosomal recessive lamellar congenital ichthyosis

Autor: Dedee F Murrell, Joyce M C Teng, Scott Guenthner, Kalyani Marathe, Steven Kempers, Kimmie Eads, Leslie Castelo-Soccio, Alan M Mendelsohn, Jessica Raiz, Christopher G Bunick

Publikováno v: Clinical and Experimental Dermatology.

BackgroundIn two severe congenital ichthyosis subtypes, autosomal recessive lamellar ichthyosis (ARCI-LI) and X-linked recessive ichthyosis (XLRI), cutaneous manifestations include widespread scaling. Approved topical treatment options are limited to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::005dcf3a2e6299e088207f1355d623f9
https://doi.org/10.1093/ced/llad033

Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery

Autor: Jessica G. Labadie, Sarah A. Ibrahim, Brandon Worley, Bianca Y. Kang, Uros Rakita, Sarah Rigali, Kenneth A. Arndt, Eric Bernstein, Jeremy A. Brauer, Sunandana Chandra, Aashish Didwania, Catherine DiGiorgio, Mattias Donelan, Jeffrey S. Dover, Hassan Galadari, Roy G. Geronemus, Mitchel P. Goldman, Merete Haedersdal, George Hruza, Omar A. Ibrahimi, Arielle Kauvar, Kristen M. Kelly, Andrew C. Krakowski, Rachel Miest, Jeffrey S. Orringer, David M. Ozog, E. Victor Ross, Peter R. Shumaker, Joseph F. Sobanko, Kathleen Suozzi, Mark B. Taylor, Joyce M. C. Teng, Nathan S. Uebelhoer, Jill Waibel, Molly Wanner, Ina Ratchev, Rachel E. Christensen, Emily Poon, Corinne H. Miller, Murad Alam

Publikováno v: Labadie, J G, Ibrahim, S A, Worley, B, Kang, B Y, Rakita, U, Rigali, S, Arndt, K A, Bernstein, E, Brauer, J A, Chandra, S, Didwania, A, Digiorgio, C, Donelan, M, Dover, J S, Galadari, H, Geronemus, R G, Goldman, M P, Haedersdal, M, Hruza, G, Ibrahimi, O A, Kauvar, A, Kelly, K M, Krakowski, A C, Miest, R, Orringer, J S, Ozog, D M, Ross, E V, Shumaker, P R, Sobanko, J F, Suozzi, K, Taylor, M B, Teng, J M C, Uebelhoer, N S, Waibel, J, Wanner, M, Ratchev, I, Christensen, R E, Poon, E, Miller, C H & Alam, M 2022, ' Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery ', JAMA Dermatology, vol. 158, no. 10, pp. 1193-1201 . https://doi.org/10.1001/jamadermatol.2022.3234
JAMA dermatology, vol 158, iss 10

ImportanceLaser-assisted drug delivery (LADD) is used for various medical and cosmetic applications. However, there is insufficient evidence-based guidance to assist clinicians performing LADD.ObjectiveTo develop recommendations for the safe and effe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4024084e4ad49e0018ee4b21e9362213
https://doi.org/10.1001/jamadermatol.2022.3234

Enstilar® (Calcipotriene and Betamethasone Dipropionate) Foam for Plaque Psoriasis in Adolescents Aged 12-17 Years

Autor: William, Abramovits, Joyce M C, Teng, Kimberly Dawn, Vincent, Aditya K, Gupta

Publikováno v: Skinmed. 18(4)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2ea4f3169d0beb19038da3420f3edb42
https://pubmed.ncbi.nlm.nih.gov/33032687

Treatment of keratitis-ichthyosis- deafness (KID) syndrome in children: a case report and review of the literature

Autor: Viraat, Patel, Grace, Sun, Meghan, Dickman, Phuong, Khuu, Joyce M C, Teng

Publikováno v: Dermatologic therapy. 28(2)

Keratitis-ichthyosis-deafness (KID) syndrome is a rare hereditary cornification disorder resulting from mutations in connexin 26, a protein important for intercellular communication. In addition to the characteristic clinical triad of congenital bila

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a72f5209e37641e55c5ddf92c2603f9c
https://pubmed.ncbi.nlm.nih.gov/25546246

A case of sclerodermatous graft-versus-host disease responsive to imatinib therapy

Autor: Jozef, Lazar, Tasneem, Poonawalla, Joyce M C, Teng

Publikováno v: Pediatric dermatology. 28(2)

Sclerodermatous graft-versus-host disease (sGVHD) is a rare, late complication of hematopoietic cell transplantation. Classified as a variant of chronic graft-versus-host disease, sGVHD is thought to be predominantly an immune-mediated response chara

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f8070b97960e3988978f95bebdbba485
https://pubmed.ncbi.nlm.nih.gov/21504445